Solutions for Life Science & Diagnostics
Anti-SLC2A13/HMIT polyclonal antibody Trial size
Additional Information
Anti-SLC2A13/HMIT polyclonal antibody Trial size Specifications
| Background: | SLC2A13, also known as HMIT (H+-myo-inositol symporter), is an odd member of the facilitatative glucose transporter family, as it specifically transports myo-inositol, not hexoses. SLC2A13 is predominantly expressed in astrocytes and neurons in the brain, suggesting that it may be involved in the control of myo-inositol brain metabolism. Dysfunctions or genetic variants of SLC2A13 associated with neuronal disorders have not yet been reported. |
| Clonality: | Polyclonal |
| Gene ID Human: | 114134 |
| Gene ID Mouse: | 239606 |
| Host Species: | Rabbit |
| Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
| Isotype: | IgG |
| Product Type: | Primary Antibody |
| Shipping: | 4 |
| Size: | 10μL |
| Status: | RUO |
| Storage: | -20 |
| Target: | SLC2A13 |
Applications:
There are no additional documents for Anti-SLC2A13/HMIT polyclonal antibody Trial size at this time.
There are no references for Anti-SLC2A13/HMIT polyclonal antibody Trial size at this time.
